Christopher Sullivan
Directeur Financier/CFO chez AVALO THERAPEUTICS, INC.
Fortune : 75 $ au 30/04/2024
Postes actifs de Christopher Sullivan
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| AVALO THERAPEUTICS, INC. | Directeur Financier/CFO | 14/02/2022 | - |
| Comptroller/Controller/Auditor | 24/04/2020 | 14/02/2022 | |
| Corporate Officer/Principal | 01/01/2018 | 24/02/2020 |
Historique de carrière de Christopher Sullivan
Anciens postes connus de Christopher Sullivan
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SUCAMPO PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01/08/2017 | 01/04/2018 |
| OPGEN, INC. | Comptroller/Controller/Auditor | 01/11/2015 | 01/08/2017 |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Corporate Officer/Principal | - | - |
Formation de Christopher Sullivan
| University of Maryland | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| Royaume-Uni | 2 |
Opérationnelle
| Comptroller/Controller/Auditor | 3 |
| Corporate Officer/Principal | 2 |
| Director of Finance/CFO | 1 |
Sectorielle
| Health Technology | 3 |
| Commercial Services | 3 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| AVALO THERAPEUTICS, INC. | Health Technology |
| OPGEN, INC. | Commercial Services |
| Entreprise privées | 2 |
|---|---|
Sucampo Pharmaceuticals, Inc.
 Sucampo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development, identification, acquisition, and delivery of innovative pharmaceutical products. The company was founded by Ryuji Ueno and Sachiko Kuno on December 5, 1996 and is headquartered in Bethesda, MD. | Health Technology |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
- Bourse
- Insiders
- Christopher Sullivan
- Expérience